“I think it's important for urologists and physicians to have an open mind in regard to complementary approaches to the treatment of BPH-related LUTS in men,” says J. Curtis Nickel, MD, FRCSC.
In this video, J. Curtis Nickel, MD, FRCSC, discusses future research on saw palmetto and why he thinks there is enough evidence to support urologists prescribing this medication to patients suffering from lower urinary tract symptoms secondary to benign prostatic hyperplasia. Nickel is a professor of urology at Queen’s University, and a research chair in urologic pain and inflammation at Kingston Health Sciences Centre, Kingston, Ontario, Canada.
Dr. Gill discusses clinical impact of the new wave of BPH treatments
October 23rd 2022In this installment of Urology Times’ 50th Anniversary Innovation Celebration, Bradley Gill, MD, MS, discusses the impact that the new wave of minimally invasive BPH treatments has had for both patients and urologists.
2 Clarke Drive
Cranbury, NJ 08512